Many of us got hired about a year ago on the promise of exciting new formulations of morphine. The lead candidate was Arymo ER which was FDA approved last week. Unfortunately the label sucks as you can read about elsewhere. Not surprisingly morale is very low. Pay and benefits are bottom quartile for the industry as you may expect for a branded generic company. The company has missed revenue forecasts throughout 2016 so bonuses are poor to zero.The head of commercial ops, Pat, who was appointed recently, is OK personally but knows little about our business. His last gig was selling cheap testosterone patches. Our CEO, Bob Radie, has never run a successful commercial operation, has little credibility now and the rumor is that he'll be fired soon due to consistent poor performance - in addition the company is under investigation for securities fraud.
So if you need a paycheck for a few months than come and join us. We should be going somewhere cool for the Arymo launch this quarter. The company just got a $40 milion loan to launch it. Most of us are looking to move out.
